Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Daily News

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

Todd Neale

November 25, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Lasers Can Aid Retrieval of Stubborn IVC Filters

Caitlin E. Cox

December 02, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

L.A. McKeown

July 23, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Daily News

Liberal IVC Filter Use Not Warranted in Severe Trauma Patients

Shelley Wood

July 08, 2019

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

L.A. McKeown

December 06, 2018

News Features

Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism

Todd Neale

January 02, 2017

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

Advertisement

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

High-Sensitivity Troponins May Overestimate PE Severity

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Lasers Can Aid Retrieval of Stubborn IVC Filters

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Liberal IVC Filter Use Not Warranted in Severe Trauma Patients

NOACs Significantly Curb Risk of VTE in Cancer Patients

Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content